聯創光電(600363.SH):中東地區對無人機反制裝備需求較爲旺盛,正積極對接當地潛在客戶及合作夥伴
格隆匯6月19日丨聯創光電(600363.SH)在互動平臺表示,公司控股子公司中久光電產業有限公司的光刃系列激光反制系統已取得出口資質,可依法依規參與符合國際準則的海外市場競爭。中東地區對無人機反制裝備需求較爲旺盛,公司正積極對接當地潛在客戶及合作夥伴,推動產品在該區域的市場拓展。公司意向客戶、潛在客戶未來是否能簽訂銷售訂單以及何時簽訂銷售訂單等各種情況仍具有較大不確定性,敬請投資者注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.